Medical Oncology

Which Cancers Are Treated by Medical Oncology?

Medical oncology is involved in the treatment of many solid tumors and selected hematological cancers.

Common examples include breast cancer, lung cancer, colorectal cancer, prostate cancer, ovarian cancer, pancreatic cancer, stomach cancer, kidney cancer, and melanoma.

The role of systemic treatment differs between cancer types.

Some patients receive medication before surgery, while others receive treatment after surgery or for advanced disease.

The objective may be curative, preventive, disease-controlling, or symptom-relieving depending on the clinical situation.

What Is Chemotherapy?

Chemotherapy uses anti-cancer drugs that interfere with cell growth and division.

It may be given intravenously, orally, or through other routes depending on the medication.

Chemotherapy can be used before surgery to reduce tumor size or after surgery to lower recurrence risk.

It may also be used as the main treatment for metastatic or advanced cancer.

Treatment is usually delivered in cycles, with rest periods that allow healthy tissues to recover.

What Is Immunotherapy?

Immunotherapy helps the immune system recognize or attack cancer cells more effectively.

Checkpoint inhibitors are among the most widely used immunotherapy drugs in modern oncology.

They target pathways that cancer cells may use to suppress immune responses.

Immunotherapy is used in selected lung cancers, melanoma, kidney cancer, bladder cancer, and several other malignancies.

Not every tumor responds to immunotherapy.

Biomarkers, cancer type, previous treatments, and general health can influence treatment suitability.

What Is Targeted Therapy?

Targeted therapy acts on specific molecular features that contribute to cancer growth or survival.

These treatments are designed to interfere with defined proteins, receptors, or genetic changes.

Examples include therapies directed at HER2, EGFR, ALK, BRAF, and other molecular targets.

Targeted treatment usually requires testing to confirm that the relevant biological feature is present.

Because cancers with the same organ of origin can have different molecular characteristics, treatment increasingly depends on tumor biology as well as tumor location.

What Is Hormone Therapy?

Hormone therapy is used for cancers that depend on hormones for growth.

It is most commonly associated with selected breast and prostate cancers.

Treatment may block hormone production or prevent hormones from interacting with cancer cells.

Hormone therapy can be used alone or combined with surgery, radiotherapy, chemotherapy, or targeted therapy.

Treatment duration may range from months to several years depending on cancer type, recurrence risk, disease stage, and response.

Why Is Molecular Testing Important?

Molecular testing can identify genetic alterations, protein expression, receptors, or other biomarkers that influence treatment decisions.

Testing may be performed on tumor tissue, blood, or both.

Results can help determine whether a patient may benefit from targeted therapy or immunotherapy.

Examples include receptor testing in breast cancer and mutation testing in selected lung, colorectal, and melanoma cases.

Molecular testing does not automatically produce a treatment option, but it can provide additional information for precision oncology.

What Is Precision Oncology?

Precision oncology uses the biological characteristics of an individual tumor to refine treatment selection.

Two cancers arising in the same organ may behave differently because their molecular profiles are different.

Precision oncology can help identify targeted drugs, immunotherapy options, or relevant clinical trials.

It also helps avoid treatments that are unlikely to work when a required biomarker is absent.

The approach is most useful when validated molecular targets and corresponding therapies are available.

How Is a Medical Oncology Treatment Plan Created?

A medical oncology treatment plan is based on the complete clinical picture rather than a single test.

The oncologist reviews pathology, tumor stage, imaging, laboratory results, molecular findings, symptoms, organ function, and previous treatment.

Performance status and other medical conditions are also important.

Treatment may involve one medication, a drug combination, or a sequence of different therapies.

The plan can change over time if the cancer responds, progresses, or causes treatment-related complications.

What Is Neoadjuvant Therapy?

Neoadjuvant therapy is systemic treatment given before the main local treatment, usually surgery.

Its purpose may be to shrink a tumor, improve surgical options, or treat microscopic disease that cannot be seen on imaging.

Chemotherapy, targeted therapy, immunotherapy, or hormone therapy may be used in the neoadjuvant setting.

The approach is common in selected breast, rectal, lung, and other cancers.

Response to preoperative treatment can also provide information about tumor behavior.

What Is Adjuvant Therapy?

Adjuvant therapy is treatment given after surgery to reduce the risk of cancer returning.

Even when a tumor has been completely removed, microscopic cancer cells may remain elsewhere in the body.

Chemotherapy, hormone therapy, immunotherapy, or targeted therapy can be used as adjuvant treatment depending on cancer type.

The need for adjuvant therapy is influenced by stage, pathology findings, lymph node involvement, molecular features, and estimated recurrence risk.

How Is Treatment Response Monitored?

Treatment response is monitored using imaging, laboratory tests, clinical examination, symptoms, and sometimes tumor markers.

CT, MRI, PET-based imaging, ultrasound, or other methods may be used depending on cancer type.

The timing of scans depends on the treatment and disease setting.

A tumor may shrink, remain stable, or continue growing despite therapy.

Treatment decisions are adjusted according to response, side effects, disease progression, and the availability of alternative therapies.

What Are the Side Effects of Cancer Treatment?

Side effects vary considerably between cancer treatments.

Chemotherapy can cause fatigue, nausea, hair loss, lowered blood counts, mouth sores, or nerve symptoms.

Targeted therapies may affect the skin, heart, liver, blood pressure, or digestive system depending on the drug.

Immunotherapy can cause inflammatory side effects involving organs such as the lungs, bowel, liver, skin, or endocrine glands.

Side-effect management is an important part of medical oncology because treatment safety influences whether therapy can continue.

What Is Supportive Care in Medical Oncology?

Supportive care aims to reduce symptoms and treatment-related complications during cancer treatment.

It may include anti-nausea medications, pain management, nutritional support, blood transfusions, infection prevention, psychological support, and management of fatigue.

Supportive care can be provided alongside curative or disease-controlling therapy.

It is not limited to advanced cancer.

Effective symptom management can help patients maintain treatment schedules, physical function, nutrition, and overall quality of life.

What Is Multidisciplinary Cancer Care?

Multidisciplinary cancer care combines expertise from different specialties to create a coordinated treatment strategy.

Medical oncologists may work with surgical oncologists, radiation oncologists, radiologists, pathologists, nuclear medicine specialists, and other clinicians.

Complex cases may be reviewed in a tumor board.

This helps determine the appropriate sequence of surgery, systemic therapy, radiotherapy, and other treatments.

Coordination is particularly important when several treatment approaches could be appropriate.

Medical Oncology in Turkey for International Patients

International patients considering medical oncology in Turkey should provide complete medical records before treatment planning.

Useful documents may include pathology reports, biopsy results, imaging, laboratory tests, molecular findings, previous chemotherapy records, surgery reports, and current medication lists.

Some pathology or imaging may need reassessment before treatment begins.

Patients receiving systemic therapy should also plan for repeated treatment cycles and follow-up.

Medical oncology in Turkey can include chemotherapy, immunotherapy, targeted therapy, hormone therapy, molecular testing, and treatment monitoring within a multidisciplinary cancer care pathway. Accurate diagnosis, evidence-based treatment selection, side-effect management, and structured follow-up remain central to oncology care.